Overview

1-Year Follow up to the 1473-IMIQ Study

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This is a 1-year follow-up study to evaluate the long-term effects in subjects who completely cleared their actinic keratosis (AK) lesions in the 1473-IMIQ study. The 1473-IMIQ study evaluated the safety and effectiveness of imiquimod 5% cream compared to a placebo cream for the treatment of AK.
Details
Lead Sponsor:
Graceway Pharmaceuticals, LLC
Treatments:
Imiquimod